GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

HALIFAX - Nova Scotia’s Progressive Conservatives say that if re-elected Nov. 26 they will introduce a universal shingles ...

Housing remained the focus of the NDP on Tuesday, as leader Claudia Chender promised to create a compliance and enforcement ...

Nova Scotia’s top party leaders are talking traffic congestion, seniors’ health and rental disputes as the provincial ...

This update in the health sector highlights major developments including DiaSorin's significant profit growth, GSK's RSV ...

Posting the video in which Trudeau was seen getting vaccine administrated, he wrote, "It’s that time of year. Take a couple ...

By Mark Gargarian Noubar and Anna Afeyan first met in 1986 at an American Chemical Society meeting in Anaheim, California.

Doctors say they are seeing an unusual spike in walking pneumonia cases in parts of Canada, particularly in kids, but their ...

Should Trump be re-elected, the CDC will likely exist on a smaller budget with a reduced role internationally. Lessons from COVID-19 show this will increase Canadian vulnerabilities.

Senate: American voters will be making multiple choices in the voting booth, electing not only the president but also members ...

Under terms of the deal, the company and the UKHSA agreed to settle the outstanding amount under dispute related to upfront ...